Details for Patent: 10,213,487
✉ Email this page to a colleague
Which drugs does patent 10,213,487 protect, and when does it expire?
Patent 10,213,487 protects BAQSIMI and is included in one NDA.
This patent has fifty-three patent family members in forty countries.
Summary for Patent: 10,213,487
| Title: | Nasal powder formulation for treatment of hypoglycemia |
| Abstract: | The present invention provides a powder formulation containing glucagon or a glucagon analog for nasal administration, useful in the treatment of hypoglycemia, and in particular the treatment of severe hypoglycemia. The present invention also provides a method of making this powder formulation, and to devices and methods for using the powder formulation. |
| Inventor(s): | Mantripragada; Sankaram (Windsor, CO), Piche; Claude A. (Verdun, CA), Van Betsbrugge; Jo Jan Filip (Laval, CA) |
| Assignee: | Eli Lilly and Company (Indianapolis, IN) |
| Application Number: | 15/545,332 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Process; Delivery; |
Drugs Protected by US Patent 10,213,487
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharms Inc | BAQSIMI | glucagon | POWDER;NASAL | 210134-001 | Jul 24, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | TREATMENT OF SEVERE HYPOGLYCEMIA IN PATIENTS WITH DIABETES | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,213,487
| PCT Information | |||
| PCT Filed | February 16, 2016 | PCT Application Number: | PCT/US2016/018003 |
| PCT Publication Date: | August 25, 2016 | PCT Publication Number: | WO2016/133863 |
International Family Members for US Patent 10,213,487
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016220235 | ⤷ Sign Up | |||
| Australia | 2021203035 | ⤷ Sign Up | |||
| Brazil | 112017014994 | ⤷ Sign Up | |||
| Canada | 2975562 | ⤷ Sign Up | |||
| Chile | 2017002031 | ⤷ Sign Up | |||
| China | 107278154 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
